Clinical trial
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV…
NCT00321828 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00321828 |
|---|---|
| Title | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery |
| Official title | A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, fluorouracil, leucovorin, oxaliplatin |
| Enrollment | 90 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Dec 1, 2012 |
| First posted | May 4, 2006 |
| Last update posted | Mar 21, 2024 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: